In Shitaoka et al., B16-specific CD8+ T cells were isolated by the sorting of CD137+PD1+CD8+ cells from tumor-infiltrating lymphocytes (TILs) and selecting enriched clones [20]. This evidence concerns the gene CD8A and neoplasm.